You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Aug 26, 2025

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Melissa M Chen1, Admir Terzic2, Anton S Becker3
1Department of Neuroradiology, MD Anderson Cancer Center, Houston, TX, USA.
This review explores how artificial intelligence is transforming cancer imaging. By analyzing complex radiographic patterns invisible to the human eye, these tools improve tumor detection, staging, and treatment monitoring, ultimately supporting more personalized cancer care.
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
05:49Author Spotlight: Advancing CBCT and Digital Dental Image Integration with AI-Assisted Digitization
Published on: February 23, 2024
Area of Science:
Background:
No prior work had resolved the full scope of computational integration within modern cancer diagnostics. Prior research has shown that radiology remains a cornerstone of patient management. It was already known that imaging provides a noninvasive window into tumor biology. That uncertainty drove the need to assess how digital processing enhances standard clinical workflows. Imaging captures the entire tumor volume, avoiding the limitations of localized tissue biopsies. These scans occur repeatedly, offering a longitudinal view of disease progression. However, the sheer volume of data often exceeds the capacity of human interpretation. This gap motivated a deeper look at how automated systems might augment diagnostic accuracy.
Purpose Of The Study:
The study aims to provide a comprehensive narrative review of emerging computational applications within the oncological imaging spectrum. This work addresses the challenge of integrating data science into modern radiology practice. Researchers sought to elaborate on new paradigms and opportunities for clinical innovation. The motivation stems from the need to improve cancer diagnosis and patient staging. Authors examined how automated systems might surpass human sensory limitations. They explored the potential for streamlining complex clinical workflows. The investigation also focused on the discovery of clinically relevant biomarkers. This effort serves to map the path toward future clinical translation in precision oncology.
Main Methods:
The authors conducted a narrative review of the current landscape regarding computational diagnostic tools. This approach involved synthesizing literature across the spectrum of cancer-related medical scans. The investigation focused on identifying emerging paradigms within the field. Researchers examined how automated systems streamline routine clinical tasks. The team evaluated the potential for discovering novel radiographic biomarkers. They also assessed the shift toward data-driven competence in radiological practice. The study design prioritized a broad overview of technical opportunities. This methodology provided a framework for understanding future clinical translation.
Main Results:
The strongest finding indicates that automated systems reveal radiographic patterns imperceptible to human sensory systems. These tools effectively streamline clinical tasks while enhancing diagnostic precision. The authors report that digital post-processing enables quantitative assessment of tumor characteristics. This capability allows for a more comprehensive evaluation than traditional sampling methods. The review highlights that imaging is routinely acquired at multiple time points. These longitudinal data points facilitate improved staging and treatment monitoring. The researchers suggest that these technical advances optimize imaging acquisition protocols. The findings collectively demonstrate a significant shift toward precision oncology applications.
Conclusions:
The authors propose that technical progress will fundamentally reshape radiological practice. Automated systems offer potential for optimizing how clinicians acquire and interpret medical scans. Researchers suggest that identifying hidden radiographic biomarkers will improve cancer staging accuracy. These tools may also enhance the precision of monitoring patient responses to therapy. The synthesis of evidence indicates that digital innovation supports the transition toward precision oncology. Authors emphasize that these advancements are moving rapidly toward clinical translation. Future efforts should focus on validating these computational models in diverse patient populations. The review highlights the shift toward data-driven decision-making in cancer care.
The researchers propose that these systems identify complex radiographic patterns imperceptible to human vision. By processing digital data, the technology reveals features that assist in diagnosing, staging, and monitoring malignancies, which differs from traditional visual inspection methods used by radiologists.
The authors describe these as quantitative assessments derived from post-processing digital scans. Unlike standard visual interpretation, these biomarkers provide objective metrics that help clinicians track disease progression more accurately than subjective human observations alone.
The authors state that competence in data science is necessary for the discipline of radiology to evolve. This technical requirement ensures that clinicians can effectively manage and interpret the complex outputs generated by automated diagnostic platforms.
The researchers utilize narrative review data to synthesize emerging paradigms. This approach allows for a comprehensive evaluation of how various computational tools integrate into existing clinical workflows, contrasting with primary clinical trials that focus on single-modality performance.
The authors measure the impact of these tools through their ability to streamline clinical tasks and reveal hidden patterns. This phenomenon contrasts with conventional imaging, which relies on human sensory systems to identify observable tumor characteristics.
The researchers propose that these advances will lead to the optimization of image acquisition. This implication suggests that future clinical translation will rely on integrating these automated systems to improve the overall quality and efficiency of cancer care.